These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 32730165)

  • 1. Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review.
    O'Brien SJ; Bishop C; Hallion J; Fiechter C; Scheurlen K; Paas M; Burton J; Galandiuk S
    Cancer Biol Ther; 2020 Sep; 21(9):769-781. PubMed ID: 32730165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA XIST expedites metastasis and modulates epithelial-mesenchymal transition in colorectal cancer.
    Chen DL; Chen LZ; Lu YX; Zhang DS; Zeng ZL; Pan ZZ; Huang P; Wang FH; Li YH; Ju HQ; Xu RH
    Cell Death Dis; 2017 Aug; 8(8):e3011. PubMed ID: 28837144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells.
    Li Y; Huang S; Li Y; Zhang W; He K; Zhao M; Lin H; Li D; Zhang H; Zheng Z; Huang C
    Tumour Biol; 2016 Oct; 37(10):14205-14215. PubMed ID: 27553025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA AB073614 induces epithelial- mesenchymal transition of colorectal cancer cells via regulating the JAK/STAT3 pathway.
    Xue J; Liao L; Yin F; Kuang H; Zhou X; Wang Y
    Cancer Biomark; 2018; 21(4):849-858. PubMed ID: 29439310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Sun J; Ding C; Yang Z; Liu T; Zhang X; Zhao C; Wang J
    J Transl Med; 2016 Feb; 14():42. PubMed ID: 26856330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
    Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
    Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased EWSAT1 expression promotes cell proliferation, invasion and epithelial-mesenchymal transition in colorectal cancer.
    Zhang R; Li JB; Yan XF; Jin K; Li WY; Xu J; Zhao J; Bai JH; Chen YZ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6801-6808. PubMed ID: 30402843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA CPS1-IT1 suppresses EMT and metastasis of colorectal cancer by inhibiting hypoxia-induced autophagy through inactivation of HIF-1α.
    Zhang W; Yuan W; Song J; Wang S; Gu X
    Biochimie; 2018 Jan; 144():21-27. PubMed ID: 29017924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer.
    Hu XT; Xing W; Zhao RS; Tan Y; Wu XF; Ao LQ; Li Z; Yao MW; Yuan M; Guo W; Li SZ; Yu J; Ao X; Xu X
    J Exp Clin Cancer Res; 2020 Dec; 39(1):270. PubMed ID: 33267897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m
    Wu Y; Yang X; Chen Z; Tian L; Jiang G; Chen F; Li J; An P; Lu L; Luo N; Du J; Shan H; Liu H; Wang H
    Mol Cancer; 2019 Apr; 18(1):87. PubMed ID: 30979372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer.
    Liang WC; Fu WM; Wong CW; Wang Y; Wang WM; Hu GX; Zhang L; Xiao LJ; Wan DC; Zhang JF; Waye MM
    Oncotarget; 2015 Sep; 6(26):22513-25. PubMed ID: 26068968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
    Ye Y; Gu B; Wang Y; Shen S; Huang W
    Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
    [No Abstract]   [Full Text] [Related]  

  • 18. Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6.
    Kong J; Sun W; Li C; Wan L; Wang S; Wu Y; Xu E; Zhang H; Lai M
    Cancer Lett; 2016 Oct; 380(2):476-484. PubMed ID: 27443606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m
    Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y
    Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.